ATE292978T1 - Zusammensetzung, welche ein eisenkomplexierendes protein und einen vorläufer im stoffwechsel von stickstoffoxid oder einen stickstoffoxid donor enthält - Google Patents
Zusammensetzung, welche ein eisenkomplexierendes protein und einen vorläufer im stoffwechsel von stickstoffoxid oder einen stickstoffoxid donor enthältInfo
- Publication number
- ATE292978T1 ATE292978T1 AT01958190T AT01958190T ATE292978T1 AT E292978 T1 ATE292978 T1 AT E292978T1 AT 01958190 T AT01958190 T AT 01958190T AT 01958190 T AT01958190 T AT 01958190T AT E292978 T1 ATE292978 T1 AT E292978T1
- Authority
- AT
- Austria
- Prior art keywords
- nitrogen oxide
- precursor
- metabolism
- composition containing
- iron complexing
- Prior art date
Links
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 title abstract 14
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 title abstract 6
- 229910052742 iron Inorganic materials 0.000 title abstract 3
- 230000004060 metabolic process Effects 0.000 title abstract 3
- 239000002243 precursor Substances 0.000 title abstract 3
- 230000000536 complexating effect Effects 0.000 title abstract 2
- 102000004169 proteins and genes Human genes 0.000 title abstract 2
- 108090000623 proteins and genes Proteins 0.000 title abstract 2
- 235000015872 dietary supplement Nutrition 0.000 abstract 2
- 150000002505 iron Chemical class 0.000 abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- 239000000126 substance Substances 0.000 abstract 2
- 208000007502 anemia Diseases 0.000 abstract 1
- 206010003549 asthenia Diseases 0.000 abstract 1
- 239000008139 complexing agent Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Neurology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Obesity (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
- Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0009883A FR2812200B1 (fr) | 2000-07-27 | 2000-07-27 | Composition contenant une proteine complexant le fer et un precurseur du metabolisme du monoxyde d'azote et/ou un donneur chimique de monoxyde d'azote ; et utilisations |
| PCT/FR2001/002469 WO2002009740A1 (fr) | 2000-07-27 | 2001-07-27 | Composition contenant une proteine complexant le fer et un precurseur du metabolisme du monoxyde d'azote et/ou un donneur chimique de monoxyde d'azote et utilisations |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE292978T1 true ATE292978T1 (de) | 2005-04-15 |
Family
ID=8852998
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01958190T ATE292978T1 (de) | 2000-07-27 | 2001-07-27 | Zusammensetzung, welche ein eisenkomplexierendes protein und einen vorläufer im stoffwechsel von stickstoffoxid oder einen stickstoffoxid donor enthält |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US6984624B2 (https=) |
| EP (1) | EP1303296B1 (https=) |
| JP (1) | JP2004520264A (https=) |
| AT (1) | ATE292978T1 (https=) |
| AU (1) | AU2001279922A1 (https=) |
| DE (1) | DE60110084D1 (https=) |
| FR (1) | FR2812200B1 (https=) |
| WO (1) | WO2002009740A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10215315A1 (de) * | 2002-04-05 | 2003-11-20 | Aventis Behring Gmbh Intellect | Human-Transferrin zur Behandlung der Anaemia of Chronic Disease (ACD) und des funktionellen Eisenmangels |
| US8126524B2 (en) | 2003-09-12 | 2012-02-28 | Or-Nim Medical Ltd. | Method and apparatus for noninvasively monitoring parameters of a region of interest in a human body |
| EP1589283B1 (en) * | 2004-04-23 | 2006-08-16 | Abb Research Ltd. | Model and control of a waste combustion process |
| RU2007117147A (ru) * | 2004-10-08 | 2008-11-20 | Юнилевер Н.В. (Nl) | Комплекс железа |
| EP1867330A4 (en) * | 2005-03-30 | 2012-01-25 | Kyowa Hakko Bio Co Ltd | METHOD FOR IMPROVING THE STORAGE STABILITY OF A SUBSTANCE |
| WO2009102677A1 (en) * | 2008-02-11 | 2009-08-20 | Tabatchnick Fine Foods, Inc. | A nutritionally enhanced therapeutic preventative food supplement and method of making same |
| JP5022454B2 (ja) * | 2008-02-14 | 2012-09-12 | 森永乳業株式会社 | 卵巣機能改善剤 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH09508097A (ja) * | 1993-11-02 | 1997-08-19 | アメリカ合衆国 | 虚血再灌流傷害における保護剤としての酸化窒素放出化合物の使用 |
| US5827729A (en) * | 1996-04-23 | 1998-10-27 | Advanced Tissue Sciences | Diffusion gradient bioreactor and extracorporeal liver device using a three-dimensional liver tissue |
| US6333311B1 (en) * | 1997-02-03 | 2001-12-25 | Pharming | Useful properties of human lactoferrin and variants thereof |
-
2000
- 2000-07-27 FR FR0009883A patent/FR2812200B1/fr not_active Expired - Fee Related
-
2001
- 2001-07-27 WO PCT/FR2001/002469 patent/WO2002009740A1/fr not_active Ceased
- 2001-07-27 DE DE60110084T patent/DE60110084D1/de not_active Expired - Lifetime
- 2001-07-27 AT AT01958190T patent/ATE292978T1/de not_active IP Right Cessation
- 2001-07-27 EP EP01958190A patent/EP1303296B1/fr not_active Expired - Lifetime
- 2001-07-27 AU AU2001279922A patent/AU2001279922A1/en not_active Abandoned
- 2001-07-27 JP JP2002515293A patent/JP2004520264A/ja active Pending
- 2001-07-27 US US10/333,554 patent/US6984624B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JP2004520264A (ja) | 2004-07-08 |
| EP1303296B1 (fr) | 2005-04-13 |
| WO2002009740A1 (fr) | 2002-02-07 |
| DE60110084D1 (de) | 2005-05-19 |
| FR2812200B1 (fr) | 2003-01-03 |
| FR2812200A1 (fr) | 2002-02-01 |
| US6984624B2 (en) | 2006-01-10 |
| US20040033945A1 (en) | 2004-02-19 |
| EP1303296A1 (fr) | 2003-04-23 |
| AU2001279922A1 (en) | 2002-02-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2007035757A3 (en) | Composition and method for treating iron deficiency anemia | |
| NO20015991D0 (no) | Bisykliske polyaminoacid-metallkomplekser, fremgangsmåter for fremstilling av disse og anvendelse i medisinsk billeddannelse | |
| IL84598A0 (en) | Pharmaceutical agents containing metal complexes | |
| MXPA03006055A (es) | Nuevos compuestos de n-fenilpirrolbisfosfano y sus complejos de metal. | |
| AU7931301A (en) | Method of using diketopiperazines and composition containing them | |
| UA34768A (uk) | Склад для обробки пар тертя | |
| NO954440L (no) | 2 pyridylmetylenpolyazamakrocyklo-fosfonsyrer, komplekser og derivater derav, for anvendelse som kontrastmidler | |
| NO954441D0 (no) | Tricyklopolyazamakrocyklofosfonsyrer, komplekser og derivater derav for anvendelse som kontrastmidler | |
| MY136095A (en) | Use of human anti-ctla-4 antibodies for treatment of cancer | |
| ATE143266T1 (de) | Komplexe und chelate des azithromycins als antiulcus-mittel | |
| ATE292978T1 (de) | Zusammensetzung, welche ein eisenkomplexierendes protein und einen vorläufer im stoffwechsel von stickstoffoxid oder einen stickstoffoxid donor enthält | |
| DE69907926D1 (de) | 1,2,4-triazol-3-thion verbindungen | |
| CA2481593A1 (en) | Biologically stable liquid composition of fviii, of vwf or of fviii/vwf complex of human origin | |
| DK1107795T3 (da) | Thiomolybdat associeret med mindst ét carbohydrat og dets anvendelse til forebyggelse eller behandling af sygdomme kendetegnet ved aberrerende vascularisation, såsom cancer, maculadegeneration af våd type, rheumatoid arthritis | |
| IL171875A0 (en) | Pioglitazone salts,such as pioglitazone sulfate, and pharmaceutical compositions and processes using the same | |
| TR199901782T2 (xx) | Migren tedavisi i�in ibuprofen ve domperidon ihtiva eden farmas�tik bile�imler. | |
| WO1999011256A8 (en) | L-threonate ferrous, as well as pharmaceutical composition and use for improving and treating human anemia thereof | |
| MY149607A (en) | Oral treatment compositions containing an anti-adhesion agent, antibacterial agent and incompatible compound | |
| WO2005039528A3 (de) | Zusammensetzung zur arthrose-/arthritisbehandlung, insbesondere von gelenken | |
| GR20000100238A (el) | Αναβραζοντα δισκια, που περιεχουν ως δραστικο συστατικο συμπλοκες ενωσεις σιδηρου, για την θεραπεια των σιδηροπενικων αναιμιων | |
| ES2188336A1 (es) | Aductos de albumina soluble con complejos polihidroxilados (polialcoholicos) de hierro trivalente, metodo de obtencion y preparaciones farmaceuticas y dieteticas que los contienen. | |
| DE60212424D1 (de) | Radiopharmazeutishes mittel zur behandlung von krebs im frühstadium | |
| HUP9700432A2 (hu) | Magnéziumot és vitaminokat tartalmazó készítmények | |
| TR200101437T2 (tr) | Tablet biçimi içindeki deterjan terkipleri | |
| GB0109194D0 (en) | Water-softener in powdered form with an effervescent system |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |